Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome

Fertility and Sterility

Volumn 94, Issue 1, 2010, Pages 173-178

  Gera, Puja S ^a   Tatpati, Laura L ^a   Allemand, Michael C ^a   Wentworth, Mark A ^a   Coddington, Charles C ^a  

^a Mayo Clinic   (United States)

Author keywords

Coasting; elective embryo cryopreservation; OHSS; ovarian hyperstimulation syndrome

Indexed keywords

ESTRADIOL;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRYOPRESERVATION; DISEASE SEVERITY; EMBRYO; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; LIVE BIRTH; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY OUTCOME; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; BIRTH RATE; COHORT STUDIES; EMBRYO TRANSFER; FEMALE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77952543083     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.02.049     Document Type: Article

References (30)

1. Budev M.M., Arroliga A.C., and Falcone T. Ovarian hyperstimulation syndrome. Crit Care Med 33 (2005) S301-S306
2. Gorkemli H., Camus M., and Clasen K. Adnexal torsion after gonadotrophin ovulation induction for IVF or ICSI and its conservative treatment. Arch Gynecol Obstet 267 (2002) 4-6
3. Cluroe A.D., and Synek B.J. A fatal case of ovarian hyperstimulation syndrome with cerebral infarction. Pathology 27 (1995) 344-346
4. Delvigne A., and Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 8 (2002) 559-577
5. Kaiser U.B. The pathogenesis of the ovarian hyperstimulation syndrome. [comment]. N Engl J Med 349 (2003) 729-732
6. Aboulghar M. Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS. Hum Reprod 18 (2003) 1140-1141
7. Levy T., Orvieto R., Homburg R., Peleg D., Dekel A., and Ben-Rafael Z. Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient. Hum Reprod 11 (1996) 1177-1179
8. Shimon I., Rubinek T., Bar-Hava I., Nass D., Hadani M., Amsterdam A., et al. Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma. J Clin Endocrinol Metab 86 (2001) 3635-3640
9. Aboulghar M.A., and Mansour R.T. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 9 (2003) 275-289
10. Kovacs P., Matyas S., and Kaali S.G. Effect of coasting on cycle outcome during in vitro fertilization/intracytoplasmic sperm injection cycles in hyper-responders. Fertil Steril 85 (2006) 913-917
11. Tummon I.S., Contag S.A., Thornhill A.R., Session D.R., Dumesic D.A., and Damario M.A. Cumulative first live birth after elective cryopreservation of all embryos due to ovarian hyperresponsiveness. Fertil Steril 81 (2004) 309-314
12. Golan A., Ron-el R., Herman A., Soffer Y., Weinraub Z., and Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 44 (1989) 430-440
13. Morris R.S., Wong I.L., Kirkman E., Gentschein E., and Paulson R.J. Inhibition of ovarian-derived prorenin to angiotensin cascade in the treatment of ovarian hyperstimulation syndrome. Hum Reprod 10 (1995) 1355-1358
14. Serour G.I., Aboulghar M., Mansour R., Sattar M.A., Amin Y., and Aboulghar H. Complications of medically assisted conception in 3,500 cycles. Fertil Steril 70 (1998) 638-642
15. American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril 86 (2006) S178-S183
16. Isik A.Z., Gokmen O., Zeyneloglu H.B., Kara S., Keles G., and Gulekli B. Intravenous albumin prevents moderate-severe ovarian hyperstimulation in in-vitro fertilization patients: a prospective, randomized and controlled study. Eur J Obstet Gynecol Reprod Biol 70 (1996) 179-183
17. Alvarez A., Marti-Bonmati L., Novella-Maestre E., Sanz R., Gomez R., Fernandez-Sanchez M., et al. Dopamine agonist Cabergoline reduces hemoconcentration and ascitesin hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab 92 (2007) 2931-2937
18. Carizza C. Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study. Reprod Biomed Online (2008) 751-755
19. Benadiva C.A., Davis O., Kligman I., Moomjy M., Liu H.C., and Rosenwaks Z. Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil Steril 67 (1997) 724-727
20. Sher G., Zouves C., Feinman M., and Maassarani G. 'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum Reprod 10 (1995) 3107-3109
21. Al-Shawaf T., Zosmer A., Hussain S., Tozer A., Panay N., Wilson C., et al. Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified coasting' strategy based on ultrasound for identification of high-risk patients. Hum Reprod 16 (2001) 24-30
22. Lee C., Tummon I., Martin J., Nisker J., Power S., and Tekpetey F. Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome?. Hum Reprod 13 (1998) 1157-1158
23. Ulug U., Bahceci M., Erden H.F., Shalev E., and Ben-Shlomo I. The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles. Hum Reprod 17 (2002) 310-313
24. Moon H.S., Joo B.S., Moon S.E., Lee S.K., Kim K.S., and Koo J.S. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome. Fertil Steril 90 (2008) 2172-2178
25. Dhont M., Van der Straeten F., and De Sutter P. Prevention of severe ovarian hyperstimulation by coasting. Fertil Steril 70 (1998) 847-850
26. Delvigne A., Kostyla K., Murillo D., Van Hoeck J., and Rozenberg S. Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome. Int J Fertil Womens Med 48 (2003) 25-31
27. Queenan Jr. J.T. Embryo freezing to prevent ovarian hyperstimulation syndrome. Mol Cell Endocrinol 169 (2000) 79-83
28. Queenan Jr. J.T., Veeck L.L., Toner J.P., Oehninger S., and Muasher S.J. Cryopreservation of all prezygotes in patients at risk of severe hyperstimulation does not eliminate the syndrome, but the chances of pregnancy are excellent with subsequent frozen-thaw transfers. Hum Reprod 12 (1997) 1573-1576
29. Ferraretti A.P., Gianaroli L., Magli C., Fortini D., Selman H.A., and Feliciani E. Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety. Hum Reprod 14 (1999) 1457-1460
30. Worrell G.A., Wijdicks E.F., Eggers S.D., Phan T., Damario M.A., and Mullany C.J. Ovarian hyperstimulation syndrome with ischemic stroke due to an intracardiac thrombus. Neurology 57 (2001) 1342-1344